Pharmaceutical Technology19m
EMA CHMP recommends AstraZeneca’s Fasenra to treat EGPA
The EMA CHMP has recommended granting approval for AstraZeneca’s Fasenra for eosinophilic granulomatosis with polyangiitis ...
cnbctv1826m
AstraZeneca shares rally 13%, hit record high as firm gets nod for cancer drug
Astrazeneca Pharma India has received CDSO's (Central Drugs Standard Control Organisation) nod for the import of Durvalumab ...
Volumes spurt at Astrazeneca Pharma India Ltd counter
Astrazeneca Pharma India Ltd registered volume of 10.98 lakh shares by 14:14 IST on NSE, a 166.41 fold spurt over two-week average daily volume of 6599 shares ...
TMCnet37m
Quell Therapeutics Expands Manufacturing Capabilities for CAR-Treg Cell Therapy Pipeline Through Partnership with eXmoor pharma
About Quell Therapeutics Quell Therapeutics is the world leader in developing engineered T-regulatory (Treg) cell therapies ...
pharmaphorum54m
Astellas claims EU okay for first claudin 18.2 cancer drug
Vyloy (zolbetuximab) has been given the go-ahead for use in combination with chemotherapy for the first-line treatment of ...